Thavarajasingam Santhosh G, El-Khatib Mahmoud, Kalb Stefania Roxana, Salih Ahmed, Ramsay Daniele S C, Thavarajasingam Ahkash, Jankovic Dragan, Ottenhausen Malte, Kalasauskas Darius, Kramer Andreas, Gutenberg Angelika, Ringel Florian
Department of Neurosurgery, LMU University Hospital, LMU Munich, Munich, Germany.
Imperial Brain and Spine Initiative, Imperial College London, London, UK.
Acta Neurochir (Wien). 2025 Sep 13;167(1):245. doi: 10.1007/s00701-025-06663-9.
Idiopathic normal pressure hydrocephalus (iNPH) is diagnosed based on a positive shunt response. However, up to 40% of patients who undergo ventriculoperitoneal (VP) shunting fail to exhibit sustained improvement. The management of iNPH remains challenging, particularly for non-responders who deteriorate despite surgery. We aimed to determine what features differentiate between long term versus short term responders and do valve adjustments affect their outcome?
We included patients that underwent ventriculoperitoneal shunt surgery for iNPH between December 2006 and December 2016. Patients were stratified as early (< 6 months) and late (> 6 months) non-responders, and responders. Descriptive statistics, time series plotting, chi-squared tests, and ANOVA analyses were used.
Our cohort of 65 iNPH patients exhibited a mean follow-up of 3.75 years and consisted of 53.8% early non-responders, 15.4% late non-responders, and 30.8% responders. Comorbidities were distributed across all groups but did not significantly differentiate between response categories. A considerable subset experienced symptom deterioration after the six months mark. Shunt valve adjustments were more frequent in non-responders but did not prevent continued deterioration. In late non-responders, valve adjustments merely slowed symptom progression, without halting deterioration.
Our study underscores that valve pressure adjustments in early non-responders, who likely never benefit from shunt surgery, are not effective, and highlights the emergence of a late non-responder phenotype, where symptom deterioration becomes evident 6 months post-shunting. Our findings outline the need to explore alternative treatment strategies for managing symptoms in iNPH non-responders, as well as prolonged follow-up regimens to monitor late non-responders.
特发性正常压力脑积水(iNPH)是根据分流反应阳性来诊断的。然而,高达40%接受脑室腹腔(VP)分流术的患者并未表现出持续改善。iNPH的管理仍然具有挑战性,特别是对于那些尽管接受了手术仍病情恶化的无反应者。我们旨在确定哪些特征可以区分长期和短期反应者,以及瓣膜调整是否会影响他们的结果?
我们纳入了2006年12月至2016年12月期间因iNPH接受脑室腹腔分流手术的患者。患者被分为早期(<6个月)和晚期(>6个月)无反应者以及反应者。使用了描述性统计、时间序列绘图、卡方检验和方差分析。
我们的65例iNPH患者队列平均随访3.75年,其中早期无反应者占53.8%,晚期无反应者占15.4%,反应者占30.8%。合并症分布在所有组中,但在反应类别之间没有显著差异。相当一部分患者在6个月后出现症状恶化。无反应者中分流瓣膜调整更频繁,但并不能阻止病情持续恶化。在晚期无反应者中,瓣膜调整只是减缓了症状进展,并未阻止病情恶化。
我们的研究强调,早期无反应者可能从未从分流手术中获益,对其进行瓣膜压力调整是无效的,并突出了晚期无反应者表型的出现,即分流术后6个月症状恶化变得明显。我们的研究结果表明,需要探索替代治疗策略来管理iNPH无反应者的症状,以及延长随访方案以监测晚期无反应者。